Electronic Health Record Strategies Can Improve Care of Patients with Heart Failure
Doctors frequently rely on the electronic health record (EHR) when caring for patients. Oftentimes, EHR systems will include clinical decision support tools that offer recommendations and reminders for physicians determining how to manage diagnosis or treatment plans.
Yale Older Adult Research Center Receives Renewed Funding
For the sixth consecutive time, the Yale Claude D. Pepper Older Americans Independence Center (OAIC) has been renewed for funding from the National Institute on Aging (NIA). The center is one of only two such programs nationwide that have received continuous NIA support since it was first funded in 1992.
New Tools Enable Non-Clinicians to Diagnose Substance Use Disorders
A new study by Yale School of Medicine (YSM) and NYU Grossman School of Medicine researchers demonstrates the validity of two new diagnostic tools—the Rapid Opioid Use Disorder Assessment and the Rapid Stimulant Use Disorder Assessment. These instruments may be used to increase diagnoses of opioid and stimulant use disorder and access to treatment.
Improving Heart Bypass Surgery Recovery for Women Takes Innovation and Representation in Research
Twenty years after a study funded by Women's Health Research at Yale uncovered that women face the risk of poorer outcomes after heart bypass surgery, new research finds the increased risk for women persists despite improved overall outcomes. But, with increased representation of women in clinical research and innovation in targets of study, we can overcome the gender gap.
New Data Reported From Trials of Drug Developed at Yale Pathology to Treat Rare, Often Fatal Neonatal Disorder
Clinical trial data from an enzyme-therapy drug developed at Yale Pathology to treat a rare and often fatal neonatal calcification disorder were recently reported. The drug, INZ-701, was designed and validated in the laboratory of Demetrios Braddock, MD, PhD, Associate Professor of Pathology at Yale School of Medicine.
Cracking Peanuts and the Code to Wilson Disease
Warren is the first person in the world to receive a groundbreaking treatment for this rare, serious genetic condition, Wilson Disease, in which excessive amounts of copper accumulates in the body, particularly in the liver and brain. Wilson Disease can cause liver and neurological damage, as well as psychiatric issues with memory, impulse control, and anger. A strong, long-term relationship between Warren and Professor of Medicine Michael Schilsky, MD, the physician who is investigating this treatment, has been essential to this novel treatment which has the potential to help patients all over the world.
Yale Department of Internal Medicine Celebrates Top Female Scientists
Last month, Research.com published the Best Female Scientists in 2022. The results were based on a ranking system which measures the impact of a researcher’s publications by combining the number of papers they have published and how often they are cited by other papers. 623 U.S.-based researchers appeared in list with three women representing the Yale Department of Internal Medicine.
Black Women Excluded from Critical Studies Due to ‘Weathering’
Researchers theorize Black women age earlier and faster as a result of being "weathered" by a lifetime of racial discrimination and race-based stressors. As a result, many Black women are excluded from clinical research studies after reaching age-based milestones earlier.
Randomized Clinical Trial Examines Facilitator-Led Interventions and Self-Administered Tools in Advance Care Planning Engagement
Patient engagement in advance care planning (ACP) is an important and yet challenging goal for clinicians. Several tradeoffs exist between facilitator-led ACP interventions and their required resources compared with self-administered tools.
Provision of Mental Health Services in the Veterans Health Administration: A Nationwide Comparison With Other Providers
On average, Veterans Health Administration (VHA) mental healthcare facilities offer significantly more treatment modalities, specialized services, and dedicated treatment programs than non-VHA facilities, according to a new study by Yale Psychiatry researchers published online in Psychiatric Services.
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.Source: YaleNews